Holen Sie sich die Stockscreener-App
19.56
0.41%
-0.08
Handel nachbörslich:
19.56
Schlusskurs vom Vortag:
$19.64
Offen:
$19.64
24-Stunden-Volumen:
197.20K
Relative Volume:
0.61
Marktkapitalisierung:
$742.16M
Einnahmen:
$95.07M
Nettoeinkommen (Verlust:
$-60.37M
KGV:
-12.01
EPS:
-1.6291
Netto-Cashflow:
$-50.92M
1W Leistung:
+0.05%
1M Leistung:
+6.42%
6M Leistung:
-16.16%
1J Leistung:
+16.71%
1-Tages-Spanne:
$19.43
$19.80
1-Wochen-Bereich:
$19.04
$20.29
52-Wochen-Spanne:
$10.85
$24.33
Ceribell Inc Stock (CBLL) Company Profile
Firmenname
Ceribell Inc
Sektor
Branche
Telefon
(800) 436-0826
Adresse
360 N. PASTORIA AVENUE, SUNNYVALE
Compare CBLL vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
19.56 | 742.16M | 95.07M | -60.37M | -50.92M | -1.6291 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-21 | Eingeleitet | Raymond James | Strong Buy |
| 2025-06-24 | Eingeleitet | BTIG Research | Buy |
| 2025-04-04 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2024-11-05 | Eingeleitet | BofA Securities | Buy |
| 2024-11-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-11-05 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-05 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Ceribell Inc Aktie (CBLL) Neueste Nachrichten
Ceribell CEO Chao sells $776,100 of company stock - Investing.com
Form 4 CeriBell Inc For: 9 July By Investing.com - Investing.com Canada
Ceribell CEO Chao sells $776,100 of company stock By Investing.com - Investing.com Canada
Form 144 Ceribell For: 7 July By Investing.com - Investing.com South Africa
Cost of goods sold of Ceribell, Inc. – DUS:W3H - TradingView
EBITDA of Ceribell, Inc. – DUS:W3H - TradingView
Ceribell CEO Chao Xingjuan sells $783,973 in stock - Investing.com
Director William Burke Sells 2,207 Shares of CeriBell Inc (CBLL) - GuruFocus
Price to book forward of CeriBell, Inc. – NASDAQ:CBLL - TradingView
Ceribell, Inc. Cash Flow – FWB:W3H - TradingView
Preferred dividends of Ceribell, Inc. – FWB:W3H - TradingView
W3H Stock Price and Chart — FWB:W3H - TradingView
Ceribell director William Burke sells $43,786 in company stock. By Investing.com - Investing.com Nigeria
Ceribell director William Burke sells $43,786 in company stock. - Investing.com
Form 4 CeriBell Inc For: 2 July By Investing.com - Investing.com Canada
Major Insider Cashes Out Big in Ceribell Stock Shake-Up - TipRanks
Ceribell(CBLL.US) Insider Sells US$4.07 Million in Common Stock - Moomoo
Form 144 Ceribell For: 30 June By Investing.com - Investing.com Nigeria
CeriBell (CBLL) Explored as Potential Candidate Among Brain-Computer Interface StocksDividend Cut Risk - dars.gov.et
Is CeriBell, Inc. (CBLL) Among the Best Brain-Computer Interface Stocks to Buy? - Yahoo Finance
CBLL Q1 2026 Earnings: Wider-than-Expected Losses Amid Pre-Revenue StageRevenue Estimate Trend - dars.gov.et
CeriBell Inc (CBLL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Ceribell, Inc. (CBLL) reports Q1 loss, beats revenue estimates - MSN
CBLL News | CERIBELL INC (NASDAQ:CBLL) - ChartMill
Ceribell, Inc. Actuals & Estimates (NASDAQ:CBLL) - TradingView
CBLL Q1 2026 Earnings: Misses EPS Estimates but Stock Gains 6%Interim Report - dars.gov.et
CBLL Forecast — Price Target — Prediction for 2027 - TradingView
CeriBell Inc (CBLL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
A Quick Look at Today's Ratings for Ceribell(CBLL.US), With a Forecast Between $28 to $30 - Moomoo
CBLL Q1 2026 Earnings: EPS Misses Estimates Amid Operational InvestmentsOne-Time Gain Impact - dars.gov.et
CBLL Q1 2026 Earnings: EPS Misses Estimates by 30.7%, Stock Edges Higher on Strategic ProgressPre-Announcement Alert - dars.gov.et
CBLL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
CeriBell Inc (CBLL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CeriBell Inc (CBLL) Valuation: PE, PB & Fair Value Analysis - TradingKey
CeriBell Inc (CBLL) Institutional Confidence - TradingKey
CeriBell Inc (CBLL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CeriBell Inc (CBLL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CeriBell Inc (CBLL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CeriBell Inc (CBLL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Ceribell, Inc. identifies hidden seizure in child using rapid EEG in emergency room - Traders Union
Insider Sell Alert: Joseph Taylor Sells 5,500 Shares of CeriBell Inc (CBLL) - GuruFocus
High-Profile Insider Move Shakes Up Investor Buzz at Ceribell, Inc. - TipRanks
Ceribell director Joseph Taylor sells $101,255 in common stock By Investing.com - Investing.com Australia
Ceribell director Joseph Taylor sells $101,255 in common stock - Investing.com
Ceribell | 4: Statement of changes in beneficial ownership of securities-Director Taylor Joseph Michael - Moomoo
CeriBell Inc. (CBLL) Q1 2026 Earnings: EPS Miss of 30.7% Highlights Rising Costs, No Revenue ReportedForward Guidance Trends - newsline.com
Ceribell, Inc. launches FDA-cleared device for bedside diagnosis and delirium monitoring - Traders Union
CBLL Q1 2026 Earnings: EPS Misses Estimates, Stock Shows ResilienceEarnings Outlook Update - newsline.com
Ceribell Insider Sold Shares Worth $714,870, According to a Recent SEC Filing - Moomoo
CBLL Q1 2026 Earnings: EPS Misses Estimates as Losses Widen, Shares DeclinePre-Earnings Drift - newsline.com
Finanzdaten der Ceribell Inc-Aktie (CBLL)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):